NAMS Forecast — Price Prediction for 2025. Should I Buy NAMS?
1-Day-Price-Prediction
-1.53%
1-Week Prediction
-1.84%
1-Month Prediction
-11.79%
2026 Prediction
+10.49%
2030 Prediction
+1575.1%
Based on our advanced algorithm, we predict that NAMS stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $36.68, while the 1-week outlook suggests a value of $36.56. For the 1-month forecast, we project a price of $32.86. Looking further ahead, our 2026 projection estimates a value of $41.16, with a long-term 2030 forecast reaching $623.98. Stay informed and make strategic decisions with our data-driven insights!
Should I Buy NewAmsterdam Pharma Company NV Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. NAMS has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
NAMS stock price ended at $36.6 on Monday, after losing-1.74%
The NewAmsterdam Pharma Company NV stock price decreased by -1.74% on the last trading day (15 Dec 2025), dropping from 36.37 to 37.25. Throughout the last trading session, the stock experienced a fluctuation of 4.20% , ranging from a day low of $35.75 to a day high of 37.25. The price has declined in 5 of the last 10 days, resulting in a total change of -9.81% during this period. On the last day, trading volume increase by -351.57K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 766.76K shares were traded, amounting to approximately 28.16M.
NAMS Technical Signals
NAMS(NewAmsterdam Pharma Company NV Corp) has 0 buy signals and 3 sell signals now. The current trend is a downtrend starting from 2025-11-26. The total price change during this trend is -11.04%. Recently, the price has dropped while volume droped, indicating a potential rebound signal. The average turnover of NAMS over the last 5 trading days is 29.83M. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
NAMS Moving Average Analysis
NewAmsterdam Pharma Company NV's overall moving average trend leans more bullish as of Monday, December 15, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $40.72, and $42.99. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $33.37, and $31.10. A break-down below any of these levels will issue sell signals.
NAMS Short Selling Analysis
The short sale ratio of NewAmsterdam Pharma Company NV(NAMS) as of 10 Dec 2025 is 19.53%, rising from last trading day. With increasing price from 34.80 to 35.61. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
3
Buy
0
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
0 Bullish Signals
0 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
No data
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-1.657
Bearish
Momentum (10 days)
MOM_10 < 0
-2.735
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.216
Bearish
NAMS Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Month
Min. Price
Avg. Price
Max. Price
Potential ROI
Jan 2026
$27.03
$31.30
$32.14
+70.74%
Feb 2026
$24.13
$30.53
$39.21
+66.54%
Mar 2026
$34.40
$35.24
$38.27
+92.27%
Apr 2026
$25.15
$33.73
$37.64
+84.03%
May 2026
$33.82
$37.13
$41.10
+102.58%
Jun 2026
$28.80
$36.58
$36.59
+99.59%
Jul 2026
$40.50
$41.82
$47.60
+128.15%
Aug 2026
$38.53
$38.75
$43.55
+111.40%
Sep 2026
$36.68
$41.26
$44.89
+125.10%
Oct 2026
$24.81
$32.88
$41.42
+79.36%
Nov 2026
$33.96
$41.82
$49.82
+128.15%
Dec 2026
$33.82
$41.16
$42.47
+124.53%
In 2026, NewAmsterdam Pharma Company NV (NAMS) is anticipated to change hands in a trading channel between $24.13 and $49.82.
NewAmsterdam Pharma Company NV Stock Forecast 2026
Jan 2026: NAMS Stock Forecast
Potential ROI: 70.74%
In Jan 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $31.30. The price is predicted to fluctuate between a low of $27.03 and a high of $32.14.
Feb 2026: NAMS Stock Forecast
Potential ROI: 66.54%
In Feb 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $30.53. The price is predicted to fluctuate between a low of $24.13 and a high of $39.21.
Mar 2026: NAMS Stock Forecast
Potential ROI: 92.27%
In Mar 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $35.24. The price is predicted to fluctuate between a low of $34.40 and a high of $38.27.
Apr 2026: NAMS Stock Forecast
Potential ROI: 84.03%
In Apr 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $33.73. The price is predicted to fluctuate between a low of $25.15 and a high of $37.64.
May 2026: NAMS Stock Forecast
Potential ROI: 102.58%
In May 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $37.13. The price is predicted to fluctuate between a low of $33.82 and a high of $41.10.
Jun 2026: NAMS Stock Forecast
Potential ROI: 99.59%
In Jun 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $36.58. The price is predicted to fluctuate between a low of $28.80 and a high of $36.59.
Jul 2026: NAMS Stock Forecast
Potential ROI: 128.15%
In Jul 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $41.82. The price is predicted to fluctuate between a low of $40.50 and a high of $47.60.
Aug 2026: NAMS Stock Forecast
Potential ROI: 111.40%
In Aug 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $38.75. The price is predicted to fluctuate between a low of $38.53 and a high of $43.55.
Sep 2026: NAMS Stock Forecast
Potential ROI: 125.10%
In Sep 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $41.26. The price is predicted to fluctuate between a low of $36.68 and a high of $44.89.
Oct 2026: NAMS Stock Forecast
Potential ROI: 79.36%
In Oct 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $32.88. The price is predicted to fluctuate between a low of $24.81 and a high of $41.42.
Nov 2026: NAMS Stock Forecast
Potential ROI: 128.15%
In Nov 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $41.82. The price is predicted to fluctuate between a low of $33.96 and a high of $49.82.
Dec 2026: NAMS Stock Forecast
Potential ROI: 124.53%
In Dec 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $41.16. The price is predicted to fluctuate between a low of $33.82 and a high of $42.47.
NAMS Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to NewAmsterdam Pharma Company NV(NAMS), our algorithm predicts NAMS's 1-month price at $36.32, with an -2.49%downwardshift. Using a similarity score up to 92.07%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for NewAmsterdam Pharma Company NV (NAMS.O) stock, as of Sunday, December 14, 2025 , forecasts a -2.49% change over the next month, based on its high correlation with EXLS.O stock patterns. The similarity between their price movements over the analyzed periods is 92.07%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
NAMS
No data
EXLS
Down: -2.49%Similarity: 92.07%
Name
Similarity
Up/Down
EXLS.O
92.07%
-2.49%
ED.N
91.40%
+2.56%
TPVG.N
91.28%
+5.30%
PLUG.O
90.62%
+16.84%
CVM.A
90.25%
-14.40%
HTCO.O
90.11%
-32.98%
RY.N
90.11%
+4.77%
MERC.O
90.04%
+1.24%
CWK.N
90.01%
+8.00%
NAMS Seasonality Analysis
Based on NAMS's historical stock price data across all years, the probability of a positive return in December is60.00%, suggesting it maybe an ideal month to invest in NAMS. In contrast,Septemberoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying NewAmsterdam Pharma Company NV (NAMS.O) stock in September has the highest probability of a positive return (80.00%), while May has the lowest probability (0.00%).
Performance Seasonality
The chart shows NewAmsterdam Pharma Company NV. (NAMS)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy NewAmsterdam Pharma Company NV (NAMS.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. NAMS has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying NewAmsterdam Pharma Company NV (NAMS.O) stock in a year?
The radar chart shows that buying NewAmsterdam Pharma Company NV (NAMS.O) stock in September has the highest probability of a positive return (80.00%), while May has the lowest probability (0.00%).
How has NewAmsterdam Pharma Company NV. (NAMS)'s stock price performed over the past three years?
NAMS's stock price fell by -0.27% in 2023,increased by 115.06% in 2024, and went up by 40.99%in 2025.
Is NAMS a buy based on overall technical signals summary?
NAMS has 0 buy signals and 3 sell signals now. Overall the technical rating for NAMS is Sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of NAMS.
What is the trend of NewAmsterdam Pharma Company NV (NAMS)'s moving average?
NewAmsterdam Pharma Company NV's overall moving average trend leans more bullish as of December 15 2025, with 1 negative signals and 3 positive signal.
What is price prediction for NAMS stock next month?
The price prediction chart for NewAmsterdam Pharma Company NV (NAMS.O) stock, as of December 14 2025, forecasts a -2.49% change over the next month, based on its high correlation with EXLS stock patterns. The similarity between their price movements over the analyzed periods is 92.07%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2026 for NewAmsterdam Pharma Company NV (NAMS) Stock?
In Dec 2026, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $41.16. The price is predicted to fluctuate between a low of $33.82 and a high of $42.47.
What is price prediction 2030 for NewAmsterdam Pharma Company NV (NAMS) Stock?
In Dec 2030, NewAmsterdam Pharma Company NV's value is forecasted to reach an average price of $623.98. The price is predicted to fluctuate between a low of $527.80 and a high of $672.71.
Positive
Negative
